Almac Group’s Diagnostics Business Unit has opened a companion diagnostic development facility, giving the company a US base to support further growth.
UK laboratory services firm LGC has brought the first BioMark system into the UK in order to accurately quantify rare gene sequences for its pharmaceutical customers.
Integrated DNA Technologies (IDT) has completed the expansion of its European production facility, enabling the company to supply its European customers faster than ever before.
Invitrogen’s plans to buy Applied Biosystems (ABI) are on track with US antitrust regulators approving the deal and both firms achieving strong revenue growth.
Nanogen has decided to pull the plug on its microarray business
after not finding any 'financially meaningful opportunities' for
it, reducing staff by 20 per cent in the process.
Applied Biosystems and BioTrove have signed a licensing and
collaboration agreement to commercialise an analysis platform for
high-throughput (HT) genotyping applications.
Two new techniques have been developed that could signal the end of
PCR (polymerase chain reaction) amplification for sequencing
applications and dramatically increase the efficiency of sample
preparation.
LabTechnologist.com brings you a round up of recent industry news,
with developments at Affymetrix, Celera, deltaDOT, Eksigent,
Farfield, Nanogen and Olympus UK.
Applied Biosystems (ABI) has successfully protected more of its PCR
(polymerase chain reaction) patents with Agilent agreeing to
license its thermal cycler technology.
Enzo Biochem has lodged an appeal after its patent infringement
claims against Applied Biosystems (ABI) were dismissed on Friday in
a summary judgement.
US-microfluidics expert Fluidigm has launched a new dynamic array
for its BioMark instrument that increases the efficiency of PCR
(polymerase chain reaction) genotyping while reducing the amount of
costly equipment and reagents needed.
SuperArray Bioscience has made available a range of pathway-focused
real-time PCR gene panels that allow scientists to use their
real-time PCR instrument just like a microarray in the multiple
stages involved in drug discovery and...
Stratagene announces a molecular diagnostics agreement, which aims
to focus on the growing molecular diagnostics market for infectious
diseases, currently worth $6.5 billion (€5.5 billion), expanding to
$12 billion by 2010 driven...
A US district court has denied a motion by Bio-Rad Laboratories to
enforce an alleged settlement agreement with Applied Biosystems
meaning the life science research product provider cannot continue
selling its thermal cycler products.
GenoID has announced a breakthrough in human papillomavirus (HPV)
testing with the first ever laboratory test kit that uses a
real-time polymerase chain reaction (real-time PCR) method to
detect all virus variants that cause cervical...
SuperArray Bioscience has introduced a product that combines the
profiling capabilities of microarrays with the performance of
real-time PCR. This novel technology will bring expression
profiling to researchers who prefer PCR based...
Roche Diagnostics has announced it has settled all litigation in
the United States, Europe and Australia, with Promega concerning
Polymerase Chain Reaction Technology (PCR), ending a decade of
litigation between the two companies.
Applied Biosystems have taken out a permanent injunction against
Bio-Rad Laboratories and its affiliate, MJ Research. This
effectively forbids these companies from making and selling
infringing thermal cycler products in the US capable...
Applied Biosystems Group reported a 40 per cent leap in profits as
the company released its forth quarter 2005 figures. The rise in
sales reflects the increased demand for biosecurity and human
identification products as well as its...
A new algorithim, that enables a more accurate deduction of
oligonucleotide (oligo) melting temperatures under laboratory
conditions, could bring improvements in primers and probe design
for use in polymerase chain reaction (PCR)...
Roche has opened the world's largest polymerase chain reaction
(PCR) manufacturing site in the world, investing more than $150
million and creating approximately 350 new jobs.
Swiss pharmaceutical firm, Hoffman-La Roche has announced its core
PCR patents have expired in an event that is expected to save
laboratories, which rely on this technology, millions of dollars a
year in royalties. It is also expected...
The ability of Applied Biosystem's 7500 Fast Real-Time PCR System
to reduce experimental time by almost three times from 2 hours to
approximately 35 minutes, in an industry standard 96-well format,
demonstrates the progress this...
Applied Biosystems has launched a polymerase chain reaction (PCR)
system that allows real-time PCR runs to proceed three times
faster. The system's quantitative results are available immediately
without gel runs, purifying PCR...
Applied DNA Sciences, a specialist in the use of DNA as a security
and anti-counterfeiting technology, is to work with the US
Department of Energy to develop an improved process for identifying
its marker technology that should bring...
Applera suffered a setback to its European sector after the
European Patent Office revoked its patent covering real-time PCR
thermal cycler technology.
The first thermal cycler to start at under £1000 (€1400) is set to
start a price war for this product, which has proved invaluable for
amplification of nucleic acids.
Applera subsidiary Applied Biosystems was awarded a US patent
covering real-time polymerase chain reaction (PCR) instruments at
the end of last week, and immediately filed lawsuits against three
rival manufacturers.
Exiqon has launched two new ProbeLibrary expression analysis kits,
covering the genomes of Arabidopsis thaliana and
Drosophila melanogaster, the most widely used models in
disease process and drug target studies.
Agilent Technologies has launched what it claims is the industry's
first fully automated, high-throughput 'lab-on-a-chip system' for
basic life science research and drug discovery. The Agilent 5100
Automated provides...
A Cambrex subsidiary has formed an alliance with Epoch Biosciences
to apply a technology usually applied in genomic analysis to
microbiological quality control for manufacturing processes.
Applied Biosystems has launched a new system for carrying out
polymerase chain reaction (PCR) experiments in 96-well plates that
can dramatically cut the time it takes to carry out the procedure.
Genomics specialist MWG Biotech has decided to pull out of
microarrays and laboratory automation and focus on its core areas
of making nucleic acids and oligonucleotides and DNA sequencing.
Applied Biosystems has been victorious in a patent dispute case,
brought in the US by Promega, that strove to overturn the company's
patents on technology used in gene amplification using polymerase
chain reaction (PCR).
Bio-Rad has completed its purchase of MJ GeneWorks, the parent
company of DNA analysis specialist MJ Research, for $32 million,
well short of the $47 million originally forecast.
Tomtec has launched a new multipurpose pipetting workstation that
can handle tiny volumes (down to less than 1 microlitre) and has
features that allows the automation of a number of routine
laboratory liquid handling tasks.
Applied Biosystems has won a legal battle in Germany that could see
certain thermal cycler products from Bio-Rad and MJ Research being
driven off the market.
After over a decade of litigation, Roche Molecular Systems has won
a 'significant legal victory' in a US court case challenging the
validity of patents on its polymerase chain reaction technology,
according to the attorney...
A prototype chip-based laboratory developed by a German company
could reduce the time it takes to carry out the DNA amplification
required for polymerase chain reactions to five minutes.
The opening up of the European market for thermal cyclers earlier
this month has been followed swiftly by the launch of a new product
in the category from Germany's MWG Biotech, reports Phil
Taylor.
MWG links up with Quanta Biotech to launch a new offensive on the
market for thermal cyclers, often described as a "must-have"
laboratory tool. The deal also marks MWG's first entry into
real-time thermal cyclers.
Switzerland's Roche is subject to a fresh legal challenge over its
patent position in polymerase chain reaction (PCR) testing, this
time from Applera unit Applied Biosystems.
